{"id":1383,"date":"2021-08-24T21:32:20","date_gmt":"2021-08-24T21:32:20","guid":{"rendered":"https:\/\/ultimatehealthreport.com\/autism-and-endocannabinoid-dysfunction-project-cbd\/"},"modified":"2021-08-24T21:32:20","modified_gmt":"2021-08-24T21:32:20","slug":"autism-and-endocannabinoid-dysfunction-project-cbd","status":"publish","type":"post","link":"https:\/\/ultimatehealthreport.com\/autism-and-endocannabinoid-dysfunction-project-cbd\/","title":{"rendered":"Autism and Endocannabinoid Dysfunction | Project CBD"},"content":{"rendered":"


\n<\/p>\n

\n

This excerpt is adapted from <\/em>The Essential Guide to CBD<\/span> by the Editors of Reader\u2019s Digest and Project CBD<\/span>.<\/em><\/p>\n

The number of children diagnosed with autism spectrum disorders (ASD<\/span>) worldwide has tripled in the past 30 years. Now there\u2019s undeniable evidence that endocannabinoid system dysregulation is involved and that some people with ASD<\/span> have low endocannabinoid system tone.<\/p>\n

In 2019, in a review paper titled \u201cEndocannabinoid system involvement in autism spectrum disorder: An overview with potential therapeutic applications,\u201d researchers concluded: \u201cRecent evidence highlights a strong involvement of the EC<\/span> system in the pathophysiology of some neuropsychiatric disorders and of ASD<\/span>\u2026. Additionally, evidence from the literature indicates that CBD<\/span> may alleviate many conditions co-occurring with ASD<\/span>, such as seizures, gastrointestinal problems, anxiety and depression, attention deficit, and sleep problems.\u201d1<\/sup><\/p>\n